Literature DB >> 8726253

Quantitative microbiology in the management of burn patients. II. Relationship between bacterial counts obtained by burn wound biopsy culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings.

J A Steer1, R P Papini, A P Wilson, D A McGrouther, N Parkhouse.   

Abstract

The use of quantitative bacteriology in the burns unit has been thought to be efficient in predicting sepsis or graft loss. To examine the relationship between clinical outcome and bacterial densities on and in the burn wound, 69 biopsy/surface swab pairs were collected from 47 patients on 64 occasions, either immediately prior to excision and grafting, or at routine change of dressings. The mean per cent TBSA burn was 16 (range 1-65). There was a significant correlation between log total bacterial count by biopsy with total white cell count and age (P = 0.028), and a significant negative correlation between total bacterial count by swab with per cent TBSA (P = 0.006). There was no significant difference in bacterial counts between patients judged to be a clinical success or clinical failure (72 h follow-up), either after undergoing excision and grafting, or change of dressings, and no difference in counts between patients with perioperative bacteraemia and those without. With burns > 15 per cent TBSA, a relationship between bacterial counts and subsequent sepsis or graft loss still was not demonstrated. It is suggested that quantitative bacteriology by burn wound biopsy or surface swab does not aid the prediction of sepsis or graft loss.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726253     DOI: 10.1016/0305-4179(95)00117-4

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  11 in total

Review 1.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

2.  Comparison of silver nylon wound dressing and silver sulfadiazine in partial burn wound therapy.

Authors:  Fereydoon Abedini; Abdollah Ahmadi; Akram Yavari; Vahid Hosseini; Sarah Mousavi
Journal:  Int Wound J       Date:  2012-06-27       Impact factor: 3.315

Review 3.  Are quantitative bacterial wound cultures useful?

Authors:  George Kallstrom
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

4.  Peri-Operative Bacteraemia in Burn Patients. What Does it Mean?

Authors:  G E Ramos; M Resta; R Durlach; O Patiño; A Bolgiani; G Prezzavento; L Fernandez Canigia; F Benaim
Journal:  Ann Burns Fire Disasters       Date:  2006-09-30

5.  Comparison of surface swab and quantitative biopsy cultures dependent on isolated microorganisms from burn wounds.

Authors:  Mete Koray Vural; Ulku Altoparlak; Demet Celebi; Mufide Nuran Akcay
Journal:  Eurasian J Med       Date:  2013-02

Review 6.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  A clinical investigation into the microbiological status of 'locally infected' leg ulcers.

Authors:  Rose A Cooper; Hanar Ameen; Patricia Price; Dorothy A McCulloch; Keith G Harding
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

8.  Antibacterial properties of tualang honey and its effect in burn wound management: a comparative study.

Authors:  Nur-Azida Mohd Nasir; Ahmad Sukari Halim; Kirnpal-Kaur Banga Singh; Ananda Aravazhi Dorai; Mehru-Nisha Muhammad Haneef
Journal:  BMC Complement Altern Med       Date:  2010-06-24       Impact factor: 3.659

Review 9.  Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance.

Authors:  Anne M Lachiewicz; Christopher G Hauck; David J Weber; Bruce A Cairns; David van Duin
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

10.  Pre-processing tissue specimens with a tissue homogenizer: clinical and microbiological evaluation.

Authors:  Erlangga Yusuf; Marieke Pronk; Mireille van Westreenen
Journal:  BMC Microbiol       Date:  2021-07-02       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.